Adapthealth (AHCO) Stock Price

Adapthealth Price

NASDAQ·CLOSED
5.74USD+0.37 (+6.57 %)
Market closed

Revenue has compounded at 38.4% per year over the past 9 years to 3.24 B USD. Earnings per share have grown at 46.6% per year over the last 6 years. Adapthealth's net margin stands at -2.2%, down from 6.4% several years earlier. Analysts set a median price target of 13.26 USD, implying 130.8% above the current price. Of 14 analysts, 11 rate the stock a buy — an overall Buy consensus. Over the past year Adapthealth shares have gained 0.4%. The stock trades about 11% above its 52-week low.

Adapthealth stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Adapthealth over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Adapthealth stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Adapthealth's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Adapthealth Stock Price History
DateAdapthealth Price
8/12/20265.74 USD
8/10/20265.38 USD
8/7/20265.69 USD
8/6/20266.05 USD
8/5/20266.58 USD
8/4/20266.53 USD
8/3/20266.53 USD
7/31/20266.51 USD
7/30/20266.44 USD
7/29/20266.60 USD
7/27/20266.57 USD
7/23/20266.31 USD
7/22/20266.56 USD
7/21/20266.76 USD
7/20/20266.62 USD
7/17/20266.61 USD
7/16/20266.57 USD
7/15/20266.39 USD
7/14/20266.14 USD
7/13/20266.24 USD
7/10/20266.16 USD
7/9/20266.13 USD
7/8/20266.05 USD
7/7/20266.12 USD
7/6/20266.48 USD
7/2/20266.49 USD
7/1/20266.39 USD
6/30/20266.28 USD
6/29/20266.19 USD
6/26/20266.20 USD
6/25/20266.04 USD
6/24/20266.05 USD
6/23/20265.85 USD
6/22/20265.79 USD
6/18/20265.76 USD
6/17/20265.91 USD
6/16/20266.18 USD
6/15/20266.04 USD
6/12/20266.17 USD
6/11/20266.07 USD
6/10/20266.04 USD
6/9/20265.91 USD
6/8/20265.82 USD
6/5/20265.99 USD
6/4/20265.91 USD
6/3/20265.78 USD
6/2/20265.92 USD
6/1/20265.96 USD
5/29/20266.16 USD
5/28/20266.11 USD
5/27/20266.20 USD
5/26/20266.19 USD
5/22/20266.30 USD
5/21/20266.26 USD
5/20/20266.25 USD
5/19/20266.24 USD
5/18/20266.46 USD
5/15/20266.43 USD
5/14/20266.48 USD
5/13/20266.52 USD
5/12/20266.78 USD
5/11/20266.78 USD
5/8/20266.81 USD
5/7/20267.07 USD
5/6/20266.89 USD
5/5/20267.08 USD
5/4/20267.86 USD
5/1/20267.94 USD
4/30/20267.90 USD
4/29/20267.89 USD
4/28/20268.07 USD
4/27/20267.89 USD
4/24/20267.72 USD
4/22/20267.66 USD
4/21/20267.33 USD
4/20/20267.64 USD
4/17/20267.63 USD
4/16/20267.59 USD
4/15/20267.63 USD
4/14/20267.70 USD
4/13/20267.43 USD
4/10/20267.34 USD
4/9/20267.37 USD
4/8/20267.34 USD
4/7/20267.20 USD
4/6/20267.28 USD
4/2/20267.25 USD
4/1/20267.15 USD
3/31/20267.18 USD
3/30/20266.81 USD
3/27/20266.75 USD
3/26/20266.88 USD
3/25/20266.87 USD
3/24/20266.82 USD
3/23/20266.38 USD
3/20/20265.98 USD
3/19/20266.08 USD
3/18/20266.08 USD
3/17/20266.30 USD
3/16/20266.28 USD
3/13/20266.52 USD
3/12/20265.88 USD
3/11/20265.88 USD
3/10/20265.85 USD
3/9/20265.88 USD
3/6/20265.72 USD
3/5/20265.79 USD
3/4/20265.83 USD
3/3/20265.67 USD
3/2/20265.81 USD
2/27/20265.52 USD
2/26/20265.48 USD
2/25/20265.63 USD
2/24/20265.34 USD
2/23/20266.20 USD
2/20/20266.23 USD
2/19/20266.06 USD
2/18/20266.24 USD
2/17/20266.21 USD
2/13/20266.15 USD
2/12/20266.08 USD
2/11/20266.36 USD
2/10/20266.42 USD
2/9/20266.46 USD
2/6/20266.42 USD
2/5/20266.32 USD
2/4/20266.05 USD
2/3/20266.10 USD
2/2/20266.09 USD
1/30/20266.22 USD
1/29/20265.90 USD
1/28/20265.80 USD
1/27/20266.07 USD
1/26/20266.17 USD
1/23/20266.08 USD
1/22/20266.33 USD
1/21/20266.34 USD
1/20/20266.27 USD
1/16/20266.40 USD
1/15/20266.42 USD
1/14/20266.36 USD
1/13/20266.40 USD
1/12/20266.39 USD
1/9/20266.32 USD
1/8/20266.40 USD
1/7/20266.33 USD
1/6/20266.08 USD
1/5/20265.90 USD
1/2/20265.83 USD
12/31/20256.01 USD
12/30/20256.10 USD
12/29/20256.13 USD
12/26/20256.18 USD
12/24/20256.17 USD
12/23/20256.10 USD
12/22/20256.20 USD
12/19/20256.01 USD
12/18/20256.17 USD
12/17/20256.32 USD
12/16/20256.24 USD
12/15/20256.19 USD
12/12/20256.27 USD
12/11/20256.18 USD
12/10/20256.20 USD
12/9/20255.72 USD
12/8/20255.66 USD
12/5/20255.68 USD
12/4/20255.66 USD
12/3/20255.63 USD
12/2/20255.69 USD
12/1/20255.88 USD
11/28/20255.82 USD
11/26/20255.79 USD
11/25/20255.84 USD
11/24/20255.95 USD
11/21/20255.78 USD
11/20/20255.49 USD
11/19/20255.49 USD
11/18/20255.49 USD
11/17/20255.63 USD
11/14/20255.54 USD
11/13/20255.63 USD
11/12/20255.62 USD
11/11/20255.79 USD
11/10/20255.67 USD
11/7/20255.76 USD
11/6/20255.79 USD
11/5/20256.23 USD
11/4/20256.43 USD
11/3/20255.48 USD
10/31/20255.42 USD
10/30/20255.40 USD
10/29/20255.54 USD
10/28/20255.71 USD
10/27/20255.67 USD
10/24/20255.55 USD
10/23/20255.57 USD
10/22/20255.69 USD
10/21/20255.81 USD
10/20/20255.71 USD
10/17/20255.55 USD
10/16/20255.50 USD
10/15/20255.58 USD
10/14/20255.45 USD
10/13/20255.35 USD
10/10/20255.19 USD
10/9/20255.40 USD
10/8/20255.40 USD
10/7/20255.44 USD
10/6/20255.40 USD
10/3/20255.59 USD
10/2/20255.55 USD
10/1/20255.49 USD
9/30/20255.40 USD
9/29/20255.40 USD
9/28/20255.23 USD
9/25/20255.36 USD
9/24/20255.26 USD
9/23/20255.41 USD
9/22/20255.34 USD
9/19/20255.37 USD
9/18/20255.56 USD
9/17/20255.48 USD
9/16/20255.56 USD
9/15/20255.49 USD
9/12/20255.69 USD
9/11/20255.75 USD
9/10/20255.52 USD
9/9/20255.57 USD
9/8/20255.68 USD
9/5/20255.79 USD
9/4/20255.55 USD
9/3/20255.48 USD
9/2/20255.52 USD
8/29/20255.70 USD
8/28/20255.57 USD
8/27/20255.55 USD
8/26/20255.55 USD
8/25/20255.57 USD
8/22/20255.80 USD
8/21/20255.62 USD
8/20/20255.63 USD
8/19/20255.75 USD
8/18/20255.66 USD
8/15/20255.73 USD
8/14/20255.72 USD
Access this data via the Eulerpool API
Get Free API Key

Adapthealth Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
3.20 B USD
-591.69 M USD
-678.90 M USD
Jan 1, 2024
3.26 B USD
263.73 M USD
90.42 M USD
Jan 1, 2025
3.24 B USD
186.27 M USD
-70.79 M USD
Jan 1, 2026 (e)
2.88 B USD
76.65 M USD
-61.36 M USD
Jan 1, 2027 (e)
2.99 B USD
81.72 M USD
-17.30 M USD
Jan 1, 2028 (e)
3.90 B USD
85.78 M USD
153.68 M USD
Jan 1, 2029 (e)
5.51 B USD
121.15 M USD
193.26 M USD
Jan 1, 2030 (e)
6.29 B USD
138.29 M USD
224.34 M USD

Adapthealth Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 14, 2026, 8:12 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
20162017201820192020202120222023202420252026e2027e2028e2029e2030e
0.170.190.350.531.062.452.973.203.263.242.882.993.905.516.29
–10.3479.6953.3399.62132.3921.037.741.88-0.49-11.343.9330.4841.2614.14
8.6215.1017.3916.6414.8718.1314.0421.2820.8917.5117.5117.5117.5117.5117.51
0.020.030.060.090.160.450.420.680.680.570.500.520.680.961.10
2.00–-1.0029.0071.00225.00207.00-591.00263.00186.0076.0081.0085.00121.00138.00
1.15–-0.295.486.729.176.97-18.478.075.732.642.712.182.202.19
-3.00–2.00-21.00-161.00156.0069.00-678.0090.00-70.00-61.00-17.00153.00193.00224.00
–––-1,150.00666.67-196.89-55.77-1,082.61-113.27-177.78-12.86-72.13-1,000.0026.1416.06
135.44135.4431.2532.7365.90136.38134.14132.99136.53135.44135.44135.44135.44135.44135.44
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Adapthealth generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Adapthealth retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Adapthealth's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Adapthealth has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Adapthealth's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Adapthealth stock margins

The Adapthealth margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Adapthealth. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Adapthealth.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
18.15 %
9.19 %
6.36 %
Jan 1, 2022
14.05 %
6.98 %
2.33 %
Jan 1, 2023
21.30 %
-18.49 %
-21.21 %
Jan 1, 2024
20.89 %
8.09 %
2.77 %
Jan 1, 2025
17.52 %
5.74 %
-2.18 %
Jan 1, 2026 (e)
17.52 %
2.66 %
-2.13 %
Jan 1, 2027 (e)
17.52 %
2.73 %
-0.58 %
Jan 1, 2028 (e)
17.52 %
2.20 %
3.94 %

Adapthealth Stock Revenue, EBIT, Earnings per Share

The Adapthealth earnings per share therefore indicates how much revenue Adapthealth has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
18.00 USD
1.65 USD
1.15 USD
Jan 1, 2022
22.15 USD
1.55 USD
0.52 USD
Jan 1, 2023
24.06 USD
-4.45 USD
-5.10 USD
Jan 1, 2024
23.88 USD
1.93 USD
0.66 USD
Jan 1, 2025
23.96 USD
1.38 USD
-0.52 USD
Jan 1, 2026 (e)
21.29 USD
0.57 USD
-0.45 USD
Jan 1, 2027 (e)
22.12 USD
0.60 USD
-0.13 USD
Jan 1, 2028 (e)
28.86 USD
0.63 USD
1.14 USD

Adapthealth business model & stock analysis

Adapthealth Corp is a leading provider of homecare products and services in the USA. It was founded in 2013 and is headquartered in Plymouth Meeting, Pennsylvania. The company started with the acquisition of NorthEast Respiratory Services (NERS), a regional provider of respiratory and sleep therapy devices in the USA. Since then, the company has made further acquisitions and expanded its range of homecare products and services. Adapthealth employs over 2,000 people and serves around half a million customers throughout North America. Its business model focuses on providing homecare products and services to help people live and care for themselves in their own homes. This includes respiratory therapy devices, sleep therapy devices, wheelchairs, walkers, and other medical aids. Adapthealth is an approved provider of Medicare and Medicaid services and works closely with insurance companies and healthcare facilities to offer its customers a wide range of products and services. Adapthealth is divided into different divisions in order to offer its customers the maximum possible range of services. These divisions are: Respiratory Therapy, Sleep Therapy, Mobility, Home Medical Equipment, and Hospice. The company aims to provide comprehensive care for its customers and offers not only product delivery and medical services, but also counseling and training. Adapthealth's employees are specialized and trained to meet the specific needs of each customer and provide the best possible care. In recent years, Adapthealth has expanded its range of homecare products and services through strategic acquisitions. One example is the acquisition of AeroCare Holdings Inc, a leading provider of home ventilators and related services in the USA. Through this acquisition, Adapthealth has further strengthened its position as a leading provider of homecare products and services in North America. In conclusion, Adapthealth Corp is a leading provider of homecare products and services in the USA. The company has demonstrated its ability to expand its activities through acquisitions and is committed to offering its customers a wide range of products and services. Adapthealth is known for its high standard of customer service and counseling, and its dedicated employees are able to meet the specific needs of each customer.

Adapthealth SWOT Analysis

Strengths

Adapthealth Corp has several strengths that contribute to its success in the market. Firstly, the company has a strong brand reputation and market presence, which helps it stand out among competitors. Secondly, Adapthealth Corp has a diverse product and service portfolio, offering a wide range of healthcare solutions to meet various customer needs. Thirdly, the company has built robust relationships with healthcare providers and insurance companies, enabling seamless collaboration and greater market access.

Weaknesses

Adapthealth Corp also faces a few weaknesses that it needs to address. One weakness is its heavy reliance on third-party suppliers, which can create supply chain vulnerabilities and potential disruptions. Additionally, the company's geographic concentration of operations may expose it to regional economic risks or regulatory challenges. Furthermore, Adapthealth Corp might face difficulty in swiftly adapting to changing technology trends, potentially limiting its ability to stay at the forefront of innovative healthcare solutions.

Opportunities

Adapthealth Corp has several opportunities in the market that it can capitalize on. Firstly, the rising global healthcare expenditure presents a favorable growth environment for the company. Moreover, the increasing trend of remote patient monitoring and telehealth services creates opportunities for Adapthealth Corp to expand its offerings and reach new customer segments. Additionally, partnerships and collaborations with technology companies or startups can facilitate the development of cutting-edge healthcare solutions, enhancing Adapthealth Corp's competitive advantage.

Threats

Adapthealth Corp faces certain threats that pose risks to its business operations. Firstly, intense competition within the healthcare industry can erode market share and put pressure on pricing and profitability. Moreover, regulatory changes and uncertainties in healthcare policies can impact the company's operations and market dynamics. Additionally, the threat of cybersecurity breaches and data privacy concerns can undermine customer trust and negatively affect Adapthealth Corp's reputation. Economic downturns or financial instability may also pose a risk to the company's financial performance.

Adapthealth Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Adapthealth Employees
Details
Date
Adapthealth Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Adapthealth Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Adapthealth historical P/E ratio, EBIT multiple, and P/S ratio

Adapthealth annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Adapthealth shares outstanding

The number of shares of Adapthealth was 135.44 M in 2025. This indicates how many shares Adapthealth is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
136.38 M Stocks
Jan 1, 2022
134.14 M Stocks
Jan 1, 2023
132.99 M Stocks
Jan 1, 2024
136.53 M Stocks
Jan 1, 2025
135.44 M Stocks
Jan 1, 2026 (e)
135.44 M Stocks
Jan 1, 2027 (e)
135.44 M Stocks
Jan 1, 2028 (e)
135.44 M Stocks

Current Adapthealth forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
78.57 % (11)
Hold
21.43 % (3)
Sell
0.00 % (0)
12M Price Target
13.26
Last Price
5.70
Currency
USD
12M Return Potential
132.63 %
LTM Return
0 %

Adapthealth Analyst Rating Actions

DateFirmActionRatingReliability
7/21/2026
Jefferies
Jefferies
UpgradeHoldBuy47
7/6/2026
Baird
Baird
MaintainedOutperform–
5/11/2026
RBC Capital
RBC Capital
MaintainedOutperform52
5/6/2026
UBS
UBS
MaintainedBuy51
5/6/2026
Canaccord Genuity
Canaccord Genuity
MaintainedBuy59
4/13/2026
Truist Securities
Truist Securities
MaintainedBuy–
2/26/2026
Leerink Partners
Leerink Partners
MaintainedOutperform–
11/6/2025
Canaccord Genuity
Canaccord Genuity
MaintainedBuy59
5/12/2025
Truist Securities
Truist Securities
MaintainedBuy–
5/8/2025
RBC Capital
RBC Capital
MaintainedOutperform52

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Adapthealth Earnings Calls

2025

Adapthealth Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/4/20260.17USD-865.56 MUSD-2026 Q2
5/5/20260.02USD-812.55 MUSD-2026 Q1
2/24/20260.36USD-848.24 MUSD-2025 Q4
5/7/20240.07USD-807.94 MUSD-2024 Q1
2/26/20240.19USD-842.80 MUSD-2023 Q4
11/6/20230.33USD-837.24 MUSD-2023 Q3
8/7/20230.28USD-808.19 MUSD-2023 Q2
5/8/20230.21USD-788.52 MUSD-2023 Q1
2/22/20230.32USD-801.00 MUSD-2022 Q4
11/8/20220.32USD-749.01 MUSD-2022 Q3

EESG©

Eulerpool ESG Scorecard© for the Adapthealth stock

13/100
3
Environment
19
Social
17
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Adapthealth shareholder structure

% Name
12.07043%
OEP CAPITAL ADVISORS, L.P.
OEP CAPITAL ADVISORS, L.P.
11.79462%
BLACKROCK, INC.
BLACKROCK, INC.
11.73906%
One Equity Partners LLC
One Equity Partners LLC
10.65638%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
8.62634%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
8.49284%
Deerfield Management Company, L.P.
Deerfield Management Company, L.P.
...

Adapthealth Beneficial Ownership Filings (SEC 13D/G)

Free Float
63.4%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
11.70%
Richard Cashin
Richard Cashin
SEC ↗
11.70%
One Equity Partners VII, L.P.
One Equity Partners VII, L.P.
SEC ↗
11.70%
One Equity Partners VII-B, L.P.
One Equity Partners VII-B, L.P.
SEC ↗
11.70%
One Equity Partners VII-A, L.P.
One Equity Partners VII-A, L.P.
SEC ↗
11.70%
OEP VII Project A-I Co-Investment Partners, L.P.
OEP VII Project A-I Co-Investment Partners, L.P.
SEC ↗
11.70%
OEP VII Project A Co-Investment Partners, L.P.
OEP VII Project A Co-Investment Partners, L.P.
SEC ↗
11.70%
OEP VII GP, L.L.C.
OEP VII GP, L.L.C.
SEC ↗
11.70%
OEP VII General Partner, L.P.
OEP VII General Partner, L.P.
SEC ↗
11.70%
OEP AHCO Investment Holdings, LLC
OEP AHCO Investment Holdings, LLC
SEC ↗
10.90%
BlackRock, Inc.
BlackRock, Inc.
SEC ↗

Adapthealth Executives and Management Board

14 members · avg. age 56 · 29 % women

SF

Ms. Suzanne Foster (55)

Chief Executive Officer, Director · since 2024

8.39 M USD

Management

JC

Mr. Jason Clemens (47)

Chief Financial Officer

6.35 M USD
AP

Mr. Albert Prast (64)

Chief Technology Officer

2.85 M USD
CA

Ms. Christine Archbold (51)

Chief Accounting Officer

1.36 M USD
TB

Mr. Toby Barnhart (57)

Chief Operating Officer

1.35 M USD
RS

Mr. Russell Schuster (48)

Chief Commercial Officer

–

Board of Directors

DW

Mr. Dale Wolf (71)

Independent Chairman of the Board

395,026.00 USD
TC

Mr. Terence Connors (70)

Independent Director

308,791.00 USD
TL

Mr. Theodore Lundberg (50)

Independent Director

303,694.00 USD
BC

Mr. Bradley Coppens (43)

Independent Director

298,034.00 USD
DW

Mr. David Williams (52)

Independent Director

285,458.00 USD
SW

Dr. Susan Weaver (64)

Independent Director

282,124.00 USD

Frequently asked questions about Adapthealth

The business model of Adapthealth Corp is focused on providing home healthcare equipment and related services. They offer a wide range of products including respiratory equipment, mobility devices, and home medical equipment to individuals with chronic illnesses or recovering from surgery. Adapthealth Corp operates through a combination of direct-to-patient delivery, retail locations, and partnerships with healthcare providers. Their goal is to improve patient outcomes by delivering high-quality equipment and personalized care. Adapthealth Corp aims to enhance patients' independence and quality of life by enabling them to receive healthcare services in the comfort of their own homes.

Adapthealth Corp is primarily active in the healthcare industry.

Some of the main competitors of Adapthealth Corp in the market include Medline Industries, Inc., Byram Healthcare, McKesson Corporation, Lincare Holdings Inc., and Apria Healthcare Group Inc.

Founded in 2012, Adapthealth Corp is a renowned healthcare company providing home medical equipment and services. It has emerged as a leading player in the industry, specializing in respiratory and home medical equipment for patients with chronic illnesses and mobility challenges. Adapthealth Corp offers a wide range of products, including respiratory and sleep therapy equipment, power mobility products, and other durable medical equipment. With a customer-centric approach, the company strives to improve patients' quality of life by ensuring easy access to personalized healthcare solutions. Adapthealth Corp's commitment to innovation, quality service, and patient care has made it a trusted name in the industry.

Adapthealth Corp has achieved several significant milestones throughout its history. The company has successfully established itself as a leader in the healthcare industry, providing innovative and personalized solutions to patients. Adapthealth Corp has expanded its operations, building a strong nationwide presence. It has formed strategic partnerships with healthcare providers, enabling it to offer comprehensive and high-quality services. The company has achieved notable financial growth, consistently delivering impressive results. Adapthealth Corp's commitment to patient care and continuous innovation has earned it industry recognition and an excellent reputation. These milestones highlight Adapthealth Corp's success in establishing itself as a reliable and trusted healthcare company.

Adapthealth Corp is primarily present in the United States.

Adapthealth Corp represents values of innovation, compassion, and patient-centered care. With a strong corporate philosophy that focuses on improving healthcare outcomes, the company aims to provide adaptable and high-quality health solutions to individuals in need. Adapthealth Corp prioritizes delivering efficient and personalized services by leveraging advancements in technology and medical expertise. By constantly adapting to the ever-evolving healthcare landscape, the company ensures that patients receive the best possible care and support. Adapthealth Corp is committed to enhancing the overall well-being of individuals and optimizing their healthcare experiences through their range of products and services.

Analysts currently set an average price target of 13.13 USD for the Adapthealth stock (median: 13.26 USD), implying +130.4 % versus the latest price. The consensus is based on 14 analyst ratings.

Adapthealth Analyst Price Targets 2026

14 analysts currently rate the Adapthealth stock: 11 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Adapthealth to generate revenue of 2.88 B USD and earnings per share of -0.45 USD.

Adapthealth Analyst Price Targets 2026

Converted at the current exchange rate, the Adapthealth share trades at 4.98 EUR (5.74 USD).

The Adapthealth share (AHCO) is listed on 1 stock exchanges, including: NASDAQ (AHCO).

AdaptHealth Corp is a leading provider of home medical products in the USA, offering a wide range of products and services tailored to the individual needs of its customers. The company was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania. AdaptHealth Corp is divided into three segments: Respiratory & HME Services, Diabetes Care, and Hospital Bed & Support Surfaces. These segments offer a wide range of products and services, including respiratory devices, masks and accessories, patient lifts, wheelchairs, walkers, and many other medical aids. The Respiratory & HME Services segment is the largest segment and includes a variety of products tailored to the needs of patients with respiratory problems and disabilities. This includes respiratory therapy devices such as CPAP and BiPAP machines, oxygen concentrators, ventilators, and other aids such as mobility scooters and wheelchairs. The company also offers HME products, including hospital beds, pressure-relief mattresses, forearm crutches, and other products that meet the daily needs of a sick or disabled individual. The Diabetes Care segment offers a wide range of diabetes management products, including blood glucose meters, insulin pumps, test strips, and many other aids. The diabetes division supports patients through training and individual consultations, providing comprehensive and specialized care. The Hospital Bed & Support Surfaces segment offers products and services such as patient lifts, wheelchairs, walkers, and other equipment that are provided to hospitals and nursing homes. This segment is an important part of the company and provides solutions that meet the daily needs of medical facilities. AdaptHealth Corp offers its customers a comprehensive service package. The company delivers products directly to the home, organizes repairs and maintenance, provides training and consultations on product usage. In this way, the company supports its customers at every stage of their treatment and provides comprehensive service, from diagnosis to rehabilitation. AdaptHealth Corp also offers a variety of online services, such as the ability to place orders online and manage invoices. Additionally, the company offers its own app that allows customers to manage their orders and appointments on the go. In summary, AdaptHealth Corp is a leading provider of home medical products in the USA, offering a wide range of specialized products and comprehensive services. The company is able to provide customized solutions to meet the needs of its customers, ensuring they receive optimal medical care.

The expected revenue of Adapthealth is 2.88 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Adapthealth is -61.36 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Adapthealth is currently -12.68. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Adapthealth stock.

The price-to-sales ratio (P/S) of Adapthealth is currently 0.27. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Adapthealth stock.

The Eulerpool Quality Score for Adapthealth is 0/10.

The ISIN of Adapthealth is US00653Q1022. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Adapthealth is A2JR26. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Adapthealth is AHCO. The ticker symbol is used to trade Adapthealth shares on the stock exchange.

Adapthealth paid dividends every year for the past 0 years.

Adapthealth is assigned to the 'Health' sector.

The dividends of Adapthealth are distributed in USD.

All fundamentals and in-depth analysis of Adapthealth

Our stock analysis for Adapthealth stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Adapthealth. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Adapthealth Stock
Adapthealth Revenue→
Adapthealth Stock
Adapthealth Net Income→
Adapthealth Stock
Adapthealth P/E→
Adapthealth Stock
Adapthealth P/S→
Adapthealth Stock
Adapthealth EBIT→
Adapthealth Stock
Adapthealth Dividend→
Adapthealth Stock
Adapthealth Directors Dealings→
Adapthealth Stock
Adapthealth Stocks→
Adapthealth Stock
Adapthealth Market capitalization→
Adapthealth Stock
Adapthealth Debt→
Adapthealth Stock
Adapthealth Liabilities→
Adapthealth Stock
Adapthealth Equity→
Adapthealth Stock
Adapthealth AAQS→
Adapthealth Stock
Adapthealth Employees→
Adapthealth Stock
Adapthealth ROE→
Adapthealth Stock
Adapthealth ROA→
Adapthealth Stock
Adapthealth ROCE→
Adapthealth Stock
Adapthealth News→
Adapthealth Stock
Adapthealth Analyst Price Targets→

Health Stocks

Adaptive BiotechnologiesAdaltaADBiotech CoAdageneADC TherapeuticsAcutus MedicalAddex TherapeuticsAcutaas ChemicalsAddex TherapeuticsAcusphereAddLifeAcurx PharmaceuticalsAll Stocks A–Z →